Long-term efficacy and safety of exemestane in the treatment of breast cancer
GA Walker,1 M Xenophontos,2 LC Chen,3 KL Cheung2 1Clinical Oncology, East Midlands Deanery, 2Breast Surgery, School of Graduate Entry Medicine and Health; 3Medicine Use, School of Pharmacy, University of Nottingham, Nottingham, UK Abstract: Exemestane, a steroidal aromatase inhibitor, is licensed fo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2013-03-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/long-term-efficacy-and-safety-of-exemestane-in-the-treatment-of-breast-a12599 |